Table 2.

Comorbidities and drug use among 941 patients with inflammatory bowel diseases (IBD) and 869 controls.

Comorbidities and drug use	IBD patients n. (%)	Controls n. (%)	p-value
Diabetes Type 1 Type 2 Hypertension Treatment with ACE inhibitors Cardiovascular diseases Liver disease Respiratory diseases Oncologic diseases Rheumatic diseases Current use of anti-inflammatory drugs Acetaminophen Aspirin Diclofenac Ibuprofen Current use of vitamin D Vaccination for seasonal influenza	45 (4.8) 8 (0.9) 37 (3.9) 194 (21.1) 52 (5.5) 58 (6.2) 29 (3.1) 52 (5.5) 35 (3.7) 138 (14.7) 603 (64.1) 80 (8.5) 99 (10.5) 150 (15.9) 364 (38.7) 270 (28.7)	50 (5.8) 7 (0.8) 43 (5.0) 200 (24.0) 51 (5.9) 53 (6.1) 28 (3.2) 57 (6.6) 76 (8.6) 75 (8.6) 444 (51.1) 145 (16.7) 137 (15.8) 274 (31.5) 276 (31.8) 190 (21.9)	0.35 0.53 0.22 0.71 0.95 0.86 0.36 <0.0001 <0.0001 <0.0001 <0.0001 0.0009 <0.0001 0.007 0.0009